No Data
$10.7 Billion Healthcare Mobile Robots Market Outlook, 2030 by Type, End Use and Region - Akebia Therapeutics, ABB, Aethon, Omron Corp., and Amazon Lead the Competition
Insider Sale: CEO and President of $AKBA Sells 97,982 Shares
BTIG Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Raises Target Price to $10
Express News | Akebia Therapeutics Inc : Btig Raises Target Price to $10 From $5
Even After Rising 18% This Past Week, Akebia Therapeutics (NASDAQ:AKBA) Shareholders Are Still Down 74% Over the Past Five Years
Akebia Therapeutics Analyst Ratings
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
